Different approaches to influenza vaccination

New England Journal of Medicine

Volumn 355, Issue 24, 2006, Pages 2586-2587

  Fukuda, Keiji ^a   Kieny, Marie Paule ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HEALTH SERVICE; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; MEDICAL PRACTICE; MEDICAL RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS MUTATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNITY, HERD; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; TREATMENT OUTCOME; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 33845503707     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068257     Document Type: Editorial

References (5)

1. King JC, Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006;355:2523-32.
2. Ohmit SE, Victor JC, Rotthof JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006;355:2513-22.
3. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
4. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006;333:912-5.
5. Global pandemic influenza action plan to increase vaccine supply. Geneva: World Health Organization, 2006. (Code no. WHO/IVB/06.13.) (Accessed November 22, 2006, at http:www.who.int/vaccines-documents/DocsPDF06/863.pdf.)